Siregar, K.B., Manuaba, T.W., Dahlan Lubis, M.N. and Sembiring, R.J. 2017. CASPASE 3 AS PROGNOSTIC MARKER FOR TRIPLE NEGATIVE BREAST CANCER CHEMOTHERAPY. Asian Journal of Pharmaceutical and Clinical Research. 10, 11 (Nov. 2017), 304–307. DOI:https://doi.org/10.22159/ajpcr.2017.v10i11.20451.